Skip to content
← Holders

Enavate Sciences GP, LLC

What Enavate Sciences GP, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1953107 · Filed Nov 16, 2026

Positions
8
Reported value
$279.8M
Opened
1
Closed
0
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$327.5M
    7 positions
  2. Dec 31, 2025$506.8M
    7 positions
  3. Mar 31, 2026$351.5M
    7 positions
  4. Jun 30, 2026$345.4M
    7 positions
  5. Sep 30, 2026$279.8M
    8 positions
SecuritySharesChangeValueOf portfolio
ZBIOZenas BioPharma, Inc.
2.9M−25.5%$78.7M28.1%
IMNMImmunome Inc.
3.6M±0%$77.7M27.8%
BRVEBraveheart Bio, Inc.
3.7MNew$74.2M26.5%
SIONSionna Therapeutics, Inc.
2.5M±0%$13M4.7%
UPBUpstream Bio, Inc.
2.5M±0%$13M4.6%
BBOTBridgeBio Oncology Therapeutics, Inc.
2.6M±0%$10.8M3.8%
CMPXCompass Therapeutics, Inc.
7.8M±0%$8.1M2.9%
CAMPCamp4 Therapeutics Corp
1M−27.0%$4.2M1.5%